Clinical data | |
---|---|
Pronunciation | /ˌɛstrəˈdaɪ.ɒl ənˈdɛsᵻleɪt/ ESS-trə-DYE-ol un-DESS-il-ayt |
Trade names | Progynon Depot 100, Delestrec, Depogin, Primogyn Depot, Progynon Depot, Oestradiol-Retard Theramex |
Routes of administration |
Intramuscular injection |
ATC code | |
Legal status | |
Legal status |
|
Identifiers | |
|
|
Synonyms | RS-1047, SQ-9993 |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
ECHA InfoCard | 100.020.616 |
Chemical and physical data | |
Formula | C29H44O3 |
Molar mass | 440.658 g/mol |
3D model (JSmol) | |
|
|
|
Estradiol undecylate (INN, USAN) (brand name Progynon Depot 100, others), or estradiol undecanoate, is a synthetic, steroidal estrogen and an estrogen ester – specifically, the 17β-undecanoate ester of estradiol – which is or has been marketed in Europe, including in Germany, the Netherlands, Switzerland, and Monaco. It acts as a prodrug of estradiol, and hence, is considered to be a natural, bioidentical form of estrogen.
Estradiol undecylate was formerly often used in very high doses (100 mg intramuscular injection every 3 weeks or once per month) to treat prostate cancer, but has since largely been superseded for this indication by newer agents with fewer adverse effects (e.g., gynecomastia and cardiovascular complications) like GnRH analogues and non-steroidal antiandrogens. Along with estradiol valerate, estradiol cypionate, and estradiol benzoate, estradiol undecylate is or has been used as an intramuscular estrogen in hormone replacement therapy for transgender women.